Roche and Atea partner to jointly develop AT-527, an orally administered direct-acting antiviral (DAA) currently in Phase 2 clinical trials
Watch world-renowned experts and connect with leading innovators on the hottest topics, new developments and latest technologies in neuroscience
The hypercube algorithm aims to enable regular, cost-effective screening in multiple contexts
The company aims to meet the increased demand for approved media to maintain virus viability from sample collection to the lab
Join us Thursday, November 5, to learn how to introduce base editing technology into your cell therapy pipeline
The TaqPath test is authorized for use with the Everlywell COVID-19 Test Home Collection Kit, which enables individuals to self-collect nasal swab specimens
Learn the importance of low LoD tests and discover the most sensitive kits available, as determined by the FDA’s SARS-CoV-2 Reference Panel
Find out how Zymo Research’s state-of-the-art tools are helping laboratories and government agencies facilitate large-scale COVID-19 testing in the United States
Experts share novel techniques for accelerating monoclonal antibody discovery and development to bring hope to COVID-19 patients
Watch this webinar on demand to learn about the host immune response to COVID-19
Watch this on-demand webinar to learn how to perform untargeted/semi-targeted metabolomic studies to discover novel biomarkers by mass spectrometry
The partnership aims to expand existing Monocyte Distribution Width (MDW) hematology-based biomarker to potentially aid in the rapid detection of MIS-C
The test uses a convolutional neural network to classify microscopy images of single intact particles of different viruses
In combination with other COVID-19 diagnostic tests, the Elecsys SARS-CoV-2 Antigen test can help in the management of patients for optimal care delivery
Availability of the new IgM blood test on the ARCHITECT and Alinity platforms is part of Abbott's effort to offer tests across the disease progression of COVID-19
Easy-to-use test, which doesn't require specialized laboratory personnel or instruments, promises flexibility to test in locations that benefit from immediate results
The CTS Rotea system aims to help researchers overcome manufacturing hurdles and bring the vast potential of cell therapies to more patients
Find out how experts at the Ellison Institute are harnessing new cell monitoring technology to build cancer cell biobanks and enhance cell line quality control and authentication
Partnership combines Twist’s leadership in DNA synthesis and synthetic biology with Neogene’s expertise in personalized engineered T cell therapies
Summa Equity Fund II acquires a majority stake in Sengenics, a functional proteomics company with a unique technology for production of full-length, correctly folded and functional proteins
Antibodies available are specific for S1, S2 and receptor-binding domain regions of SARS-CoV-2 Spike protein
The CleanPlex ACE2 & TMPRSS2 Panel assesses differences in patients’ genetic susceptibility to COVID-19 infection and to developing severe disease
